Cap

Zacks Small Cap Analysis – XFOR: First Business Gross sales of XOLREMDI… – Go Well being Professional

by
Zacks Small Cap Analysis – XFOR: First Business Gross sales of XOLREMDI… – Go Well being Professional

By David Bautz, PhD NASDAQ:XFOR READ THE FULL XFOR RESEARCH REPORT Monetary Replace On August 8, 2024, X4 Prescription drugs, Inc. (NASDAQ:XFOR) introduced monetary outcomes for the second quarter of 2024. The corporate recorded the primary revenues for XOLREMDI following its industrial launch in April 2024. Income within the second quarter of 2024 totaled $0.6 … Read more

Zacks Small Cap Analysis – NVX: Advancing NVX Cathode Supplies Unit; CFO Transition Anticipated to be Easy – Go Well being Professional

by

By M. Marin NASDAQ:NVX Novonix Cathode Supplies – important for lithium-ion batteries Novonix (NASDAQ:NVX) is advancing each its Cathode and Anode supplies items because it continues its technique to develop a north American provide chain to help the battery business. With Novonix Cathode Supplies anticipated to play a key position as demand for batteries grows, … Read more

x